AKRO
Ticker
Akero Therapeutics, Inc.
AKROAKRO has 3 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 0 purchases and 3 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Oct 10 2025 and filed Oct 14 2025. The most active filer was Andrew Cheng with 15 filings.
Add to watchlistFilings, ttm
3
0 buys · 3 sells
Traders, ttm
3
3 insiders
Volume, ttmiDollar value disclosed in the window
$2.7M
estimated for Congress, as filed for insiders
Median delay
2d
execution to disclosure
Last traded
Oct 10 2025
Filed Oct 14 2025
ADViAverage daily dollar volume
–
not on file
No price series on file for AKRO yet.
Volume by month
Buys $18.4M
Sells $51.2M
Estimated for Congress, as filed for insiders · by filing month · past 24 months
Who filed
AC
Andrew Cheng
President and CEO
15 filings
CY
Catriona Yale
Chief Development Officer
15 filings
TR
Timothy Rolph
Chief Scientific Officer
13 filings
JY
Jonathan Young
Chief Operating Officer
11 filings
PL
Patrick Lamy
Senior VP, Commercial Strategy
5 filings
GG
G. Walmsley Graham
Director
2 filings
JHRecent filings
Andrew ChengSALE
President and CEO
$1.6M30,000 sh × $53.98
Exec Oct 10 2025
Filed Oct 14 2025 · 5:30 PM ET Timothy RolphSALE Chief Scientific Officer $527K
11,463 sh × $46.01
Exec Oct 7 2025
Filed Oct 9 2025 · 5:30 PM ET Jonathan YoungSALE Chief Operating Officer $597K
12,500 sh across 2 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET Andrew ChengSALE President and CEO $1.3M
29,842 sh across 2 lots
Exec Sep 10 2025
Filed Sep 12 2025 · 5:30 PM ET Timothy RolphSALE Chief Scientific Officer $551K
12,466 sh × $44.17
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET Jonathan YoungSALE Chief Operating Officer $573K
12,439 sh across 2 lots
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET Andrew ChengSALE President and CEO $1.4M
29,600 sh across 2 lots
Exec Aug 11 2025
Filed Aug 13 2025 · 5:30 PM ET Jonathan YoungSALE Chief Operating Officer $532K
11,151 sh × $47.72
Exec Aug 12 2025
Filed Aug 13 2025 · 5:30 PM ET Jane HendersonSALE Director $142K
3,000 sh × $47.46
Exec Aug 12 2025
Filed Aug 12 2025 · 5:30 PM ET Timothy RolphSALE Chief Scientific Officer $616K
12,500 sh across 2 lots
Exec Aug 5 2025
Filed Aug 7 2025 · 5:30 PM ET Catriona YaleSALE Chief Development Officer $458K
8,658 sh × $52.87
Exec Jul 16 2025
Filed Jul 18 2025 · 5:30 PM ET Andrew ChengSALE President and CEO $1.5M
30,000 sh across 2 lots
Exec Jul 10 2025
Filed Jul 11 2025 · 5:30 PM ET Timothy RolphSALE Chief Scientific Officer $542K
10,634 sh × $50.93
Exec Jul 7 2025
Filed Jul 9 2025 · 5:30 PM ET Patrick LamySALE Senior VP, Commercial Strategy $106K
2,000 sh × $52.88
Exec Jul 1 2025
Filed Jul 3 2025 · 5:30 PM ET Catriona YaleSALE Chief Development Officer $493K
9,105 sh across 2 lots
Exec Jun 16 2025
Filed Jun 20 2025 · 5:30 PM ET † Andrew ChengSALE President and CEO $363K
6,620 sh × $54.84
Exec Jun 18 2025
Filed Jun 20 2025 · 5:30 PM ET Jonathan YoungSALE Chief Operating Officer $135K
2,493 sh × $53.99
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET Catriona YaleSALE Chief Development Officer $151K
2,803 sh × $54.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET William Richard WhiteSALE Chief Financial Officer $151K
2,804 sh × $54.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET Timothy RolphSALE Chief Scientific Officer $127K
2,358 sh × $54.00
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET Andrew ChengSALE President and CEO $2.0M
37,837 sh across 3 lots
Exec Jun 10 2025
Filed Jun 12 2025 · 5:30 PM ET Timothy RolphSALE Chief Scientific Officer $2.0M
37,500 sh across 3 lots
Exec Jun 5 2025
Filed Jun 9 2025 · 5:30 PM ET Patrick LamySALE Senior VP, Commercial Strategy $167K
3,300 sh × $50.46
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET Patrick LamySALE Senior VP, Commercial Strategy $200K
4,000 sh × $50.00
Exec May 22 2025
Filed May 23 2025 · 5:30 PM ET Catriona YaleSALE Chief Development Officer $393K
10,000 sh across 3 lots
Exec May 15 2025
Filed May 19 2025 · 5:30 PM ET